Hikma Pharmaceutical | Cassa E Equivalenti



Cash And Equivalent Cambiamento Data
Almirall EUR 329.41M 15.11M 2024-06
AstraZeneca USD 5.23B 258M 2025-03
Bayer EUR 6.19B 1.57B 2024-12
Fresenius EUR 2.28B 788M 2024-12
Galapagos EUR 108.07M 43.83M 2025-03
Genmab DKK 9.86B 3.52B 2024-12
GlaxoSmithKline GBP 4.46B 594M 2025-03
GRIFOLS EUR 979.78M 334.84M 2024-12
Hikma Pharmaceutical USD 0 1000K 2024-06
Lonza CHF 1.11B 286M 2024-12
Merck EUR 2.15B 1.01B 2024-12
Orion EUR 259.4M 53.8M 2025-03
Recordati EUR 235.02M 34.44M 2024-09
Roche Holding CHF 6.98B 2.15B 2024-12
Sanofi 7.99B 550M 2025-03
UCB EUR 1.57B 1.14B 2024-12



Hikma Pharmaceutical Cassa E Equivalenti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.